• Users Online: 3365
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity

Sangtam Tiakumzuk, Vinekar Anand, Maheshwar Bakthavatsalu, Dogra Mangat R, Eong Kah-Guan Au

Year : 2007| Volume: 55| Issue : 4 | Page no: 317-317

   This article has been cited by
1 Refractive and biometrical characteristics of children with retinopathy of prematurity who received laser photocoagulation or intravitreal ranibizumab injection
Xiaofeng Lu, Xianlu Zeng, Miaohong Chen, Zixin Fan, Lei Zheng, Ya Tian, Shaochong Zhang, Ji C. He, Guoming Zhang
Graefe's Archive for Clinical and Experimental Ophthalmology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease
Marcel N Menke,Carsten Framme,Mathias Nelle,Markus R Berger,Veit Sturm,Sebastian Wolf
BMC Ophthalmology. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]
3 Bevacizumab (Avastin) for the Treatment of Ocular Disease
Gunther, J.B., Altaweel, M.M.
Survey of Ophthalmology. 2009; 54(3): 372-400
[Pubmed]  [Google Scholar]
4 Bevacizumab (Avastin) for the Treatment of Ocular Disease
Jonathan B. Gunther,Michael M. Altaweel
Survey of Ophthalmology. 2009; 54(3): 372
[Pubmed]  [Google Scholar] [DOI]


Read this article